Hongmei Yi
Shanghai Jiao Tong University(CN)Ruijin Hospital(CN)Shanghai Institute of Hematology(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Immune Cell Function and Interaction
Most-Cited Works
- → Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis(2022)170 cited
- → Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial(2023)103 cited
- → DigestPath: A benchmark dataset with challenge review for the pathological detection and segmentation of digestive-system(2022)82 cited
- → Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B‐cell lymphoma(2020)78 cited
- → Concurrent remission of lymphoma and Sjögren’s disease following anti-CD19 chimeric antigen receptor-T cell therapy for diffuse large B-cell lymphoma: a case report(2023)43 cited
- → Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study(2022)33 cited
- → Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China(2021)31 cited
- → Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma(2022)25 cited
- → B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases(2021)20 cited
- → Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma(2024)20 cited